At the Heart of Vireon Lab’s Competencies
From R&D to Retail Pharmacy
Pakistan’s pharmaceutical sector is large and growing; it was worth around ₨748 billion (US$2.6 billion) in 2023 and has since surged, with retail pharma sales crossing ₨1.049 trillion by early 2025. The country hosts over 800 pharmaceutical manufacturing units, including 25 multinationals, which collectively meet about 90% of domestic medicine demand in volume.
This robust local industry co-exists with a heavy reliance on imports for specialized medicines and raw materials – over 90% of pharmaceutical raw materials are imported, and certain high-tech or specialty drugs are brought in finished form.
Know More on the Pakistani Pharmaceutical Market!
Contact UsFor International Companies
For international pharma companies, we facilitate entry into this promising market by handling drug registrations, clinical trial approvals if needed, and DRAP compliance for imports. Pakistan’s regulator, DRAP, not only oversees drug quality but also controls pricing of many medications, making it crucial to have local insight when launching products.
We advise on pricing strategy within the regulated regime to ensure both compliance and commercial viability.
For Local Companies
For local pharmaceutical manufacturers, we offer consultancy to expand product portfolios, obtain quality certifications (e.g. WHO GMP pre-qualification), and even support exporting by aligning with international regulations. We are also familiar with procurement processes and can assist in selling to government healthcare programs or tenders, which is important for essential medicines.
Assistance to local pharmaceutical sector in every possible regulatory and marketing aspects.
What our Team Can Do?
Our team’s deep knowledge of therapeutic areas (from generics to complex biologics) and pharmacovigilance ensures that whether it’s a new cardiovascular drug, an oncology therapy, or a simple painkiller, we can help manage the regulatory paperwork and strategize the market positioning. We keep track of pharmaceutical policy changes in Pakistan, such as any shifts in drug scheduling, generic substitution laws, or local manufacturing incentives, to proactively advise our clients. In essence, Vireon Lab serves as a bridge between pharmaceutical innovation and the Pakistani patient population – making sure effective medicines don’t face delays in reaching those who need them due to compliance or market hurdles.
We make sure effective medicines don’t face delays in reaching those who need them due to compliance or market hurdles.
